chemotherapy: be given through central line

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be given through central line 1.00
be given through line 0.93
be given in form 0.79
is given 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.56
Similarity weight: 0.76
Evidence: 0.51
¬ Remarkable(chemotherapy, be given through central line)
Evidence: 0.86
¬ Remarkable(dialysis, is given)

Remarkability from sibling implausibility

0.44
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.54
Plausible(chemotherapy, be given through central line)
Evidence: 0.86
Remarkable(dialysis, is given)
Evidence: 0.44
¬ Plausible(dialysis, is given)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.54
Plausible(chemotherapy, be given through central line)
Evidence: 0.56
¬ Salient(chemotherapy, be given through central line)

Similarity expansion

0.64
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.93
Evidence: 0.61
Typical(chemotherapy, be given through central line)
Evidence: 0.49
¬ Typical(chemotherapy, be given through line)
0.63
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.61
Typical(chemotherapy, be given through central line)
Evidence: 0.07
¬ Typical(chemotherapy, is given)
0.63
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.93
Evidence: 0.56
Salient(chemotherapy, be given through central line)
Evidence: 0.48
¬ Salient(chemotherapy, be given through line)
0.62
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.93
Evidence: 0.54
Plausible(chemotherapy, be given through central line)
Evidence: 0.46
¬ Plausible(chemotherapy, be given through line)
0.61
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.79
Evidence: 0.61
Typical(chemotherapy, be given through central line)
Evidence: 0.23
¬ Typical(chemotherapy, be given in form)
0.58
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.93
Evidence: 0.51
Remarkable(chemotherapy, be given through central line)
Evidence: 0.56
¬ Remarkable(chemotherapy, be given through line)
0.56
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.76
Evidence: 0.54
Plausible(chemotherapy, be given through central line)
Evidence: 0.29
¬ Plausible(chemotherapy, is given)
0.55
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.79
Evidence: 0.54
Plausible(chemotherapy, be given through central line)
Evidence: 0.41
¬ Plausible(chemotherapy, be given in form)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.56
Salient(chemotherapy, be given through central line)
Evidence: 0.54
¬ Salient(chemotherapy, is given)
0.48
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.79
Evidence: 0.56
Salient(chemotherapy, be given through central line)
Evidence: 0.64
¬ Salient(chemotherapy, be given in form)
0.38
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.79
Evidence: 0.51
Remarkable(chemotherapy, be given through central line)
Evidence: 0.90
¬ Remarkable(chemotherapy, be given in form)
0.35
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.76
Evidence: 0.51
Remarkable(chemotherapy, be given through central line)
Evidence: 0.95
¬ Remarkable(chemotherapy, is given)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.56
Salient(chemotherapy, be given through central line)
Evidence: 0.61
¬ Typical(chemotherapy, be given through central line)
Evidence: 0.51
¬ Remarkable(chemotherapy, be given through central line)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.54
Plausible(chemotherapy, be given through central line)
Evidence: 0.61
¬ Typical(chemotherapy, be given through central line)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.51
¬ Remarkable(chemotherapy, be given through central line)
Evidence: 0.29
¬ Typical(dialysis, is given)